Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
The treatment of multiple myeloma patients not eligible for asctPaul Richardson, Jacob Laubach, Anuj Mahindra, et al.
Cancer Research|May 17, 2003
Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusionEnrica Orsini, Roberto Bellucci, Edwin P Alyea, et al.
Blood|June 26, 2004
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Cancer Management and Research|December 29, 2010
Bortezomib in the management of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Teru Hideshima, et al.
Seminars in Oncology|April 30, 2003
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerationsSteven P Treon, Abigail Kelliher, Beverly Keele, et al.
British Journal of Haematology|July 8, 2011
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settingsPaul G Richardson, Jacob Laubach, Constantine S Mitsiades, et al.
Blood|October 24, 2002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Constantine Mitsiades, Masaharu Akiyama, et al.
Leukemia & Lymphoma|June 14, 2022
Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myelomaMatthew Ho, Maria Moscvin, Soon Khai Low, et al.
Oncology (Williston Park, N.Y.)|August 29, 2007
Novel therapeutic avenues in myeloma: changing the treatment paradigmJoanne Ghobrial, Irene M Ghobrial, Constantine Mitsiades, et al.
Blood|May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myelomaRoberto Bellucci, Edwin P Alyea, Edie Weller, et al.
Pageof 5